Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is designed to influence metabolic regulation by enhancing insulin secretion, reducing glucagon levels, and slowing gastric emptying.

Research suggests tirzepatide may:

• Improve blood glucose control by increasing insulin sensitivity

• Reduce appetite and food intake

• Support weight loss through effects on energy balance

• Influence lipid metabolism and overall metabolic function

By targeting both GIP and GLP-1 pathways, tirzepatide may offer a broader metabolic impact compared to single-receptor agonists.

Tirzepatide is intended for research and laboratory use only.